U.S. FDA Approves IMBRUVICA® (ibrutinib) for the Treatment of Waldenström’s Macroglobulinemia: First FDA-Approved Therapy for This Disease

Please click here to ready the Full Press Release: Janssen WM PDUFA Press Release FINAL

New Breast Cancer Risk Prediction Model

A new breast cancer risk prediction model combining histologic features of biopsied breast tissue from women with benign breast disease and individual patient demographic information more accurately classified breast cancer risk than the current screening standard. Results of a Mayo Clinic study comparing the new model to the current standard, the Breast Cancer Risk Assessment Tool, are published in the Journal of Clinical Oncology. (more…)

Diabetes Drugs Take Backseat To Cancer Diagnosis As People Forget About Condition

Diabetes patients who are diagnosed with cancer tend to neglect their medication.

Health care professionals are currently trying to learn more about the connection between diabetes and cancer, including how many diabetes patients are also dealing with a cancer diagnosis. A recent study published in the journal of the European Association for the Study of Diabetes Diabetologia has revealed that diabetes patients who are diagnosed with cancer often struggle with adhering to their diabetes medication. (more…)

Prostate Cancer Treatment: Surgery or Radiation?

Weighing the pros and cons of both treatment options. Both surgery and radiation carry potential complications and side effects that patients must consider.

While a growing number of men diagnosed with early-stage, slow-growing prostate cancer opt for no immediate treatment beyond active surveillance, most men diagnosed with the cancer – especially those under age 60 who are in good health with a long life expectancy – choose to have their cancer treated without delay with either surgery or radiation. (more…)

Putting Precision Medicine For Cancer At Work In America’s Largest Hospital

In one of the largest initiatives of its kind, the for-profit hospital chain Hospital Corporation of America (HCA) has embarked on a plan to molecularly profile the tumor of cancer patients, marry the genomic information to clinical data from a patient’s electronic health record, and recommend targeted therapies. (more…)

Pancreatic Cancer: Targeted Treatments Hold Promise

Scientists are working to develop breakthrough therapies for pancreatic cancer, one of the deadliest cancers affecting both men and women.

Pancreatic cancer is a disease that frequently presents no symptoms until it reaches very advanced stages. Surgery is the only chance for a cure, but most patients are not surgical candidates because of the location of the tumor in the pancreas or because the cancer has spread. Moreover, most people who undergo surgery relapse and subsequently die of pancreatic cancer. (more…)

When Health-Care Reforms Don’t Add Up

The Barack Obama administration has announced plans to tie 90 percent of all Medicare fee-for-service payments to some sort of quality or value measure by 2018. Sounds exciting! Who wouldn’t like to ensure that their doctors are paid for delivering value, rather than just randomly sticking needles into us? (more…)

Myriad Genetics Ending Patent Dispute on Breast Cancer Risk Testing

Myriad Genetics has essentially given up trying to stop other companies from offering tests for increased risk of breast cancer, ending a dispute that was the subject of a landmark Supreme Court ruling that human genes cannot be patented.

The company has settled or is in the process of settling patent-infringement lawsuits it filed against other companies that now offer such testing, a Myriad spokesman said on Tuesday. (more…)

How to Fix Meaningful Use to Help Physicians

5 ways physician advocate groups recommend the federal government can overhaul the meaningful use program to make it more flexible for physicians

While the U.S. Centers for Medicare and Medicaid Services (CMS) and the Office of the National Coordinator for Health Information Technology (ONC) have made tweaks to the meaningful use (MU) program to help physicians attest to stage 2, many physicians are still struggling with the burden. (more…)

E&C Chairman Upton Releases Draft of 21st Century Cures Bill

The 21st Century Cures initiative, legislation “to take a comprehensive look at what steps we can take to accelerate the pace of cures in America” has moved from the concept phase to draft bill language. (more…)